(NUTX) Nutex Health - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US67079U1088

NUTX: Hospitals, Healthcare, Real Estate, Imaging, Laboratories, Pharmacies

Nutex Health Inc. (NASDAQ:NUTX) is a physician-led healthcare services and operations company that operates through three distinct segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment includes a network of micro-hospitals, specialty hospitals, and hospital outpatient departments, offering 24/7 emergency care, inpatient services, and behavioral health support. Additionally, this segment provides onsite imaging services such as CT scans, X-rays, MRIs, and ultrasounds, as well as certified laboratories and inpatient pharmacies.

The Population Health Management segment focuses on establishing and operating independent physician associations (IPAs) and offers a cloud-based platform designed to enable healthcare organizations to deliver value-based care and manage population health effectively. This platform supports data-driven decision-making, care coordination, and patient engagement, aligning with the shift toward value-based care models in the healthcare industry.

The Real Estate segment involves the ownership and leasing of land and hospital buildings, providing the necessary infrastructure to support the companys healthcare operations. This segment plays a critical role in ensuring that Nutex Healths facilities are well-maintained and strategically located to meet patient needs.

In addition to its core operations, Nutex Health provides a range of operational and managerial services, including management, billing, collections, human resources, legal, accounting, and marketing support. These services are designed to streamline operations for healthcare providers, allowing them to focus on delivering high-quality patient care.

Nutex Health was founded in 2011 and is headquartered in Houston, Texas. The companys integrated approach to healthcare delivery, combining operational efficiency with advanced technology, positions it as a key player in the evolving healthcare landscape. For more information, visit their website at https://www.nutexhealth.com.

Ticker Symbol: NUTX
Exchange: NASDAQ
Type: common stock
Country Origin: United States
GICS Sub Industry: Health Care Equipment

3-Month Forecast:
Based on the provided and , Nutex Health Inc. is expected to experience moderate volatility with an average trading volume of 45,672 shares over 20 days. The stock is currently priced at $54.90, with a 20-day SMA of $57.40 and a 200-day SMA of $24.06, indicating a recent upward trend. The ATR of 3.94 suggests potential price fluctuations. Fundamentally, the company has a market cap of $359.17M, a P/B ratio of 5.94, and a P/S ratio of 1.23, reflecting its valuation metrics. The lack of P/E and forward P/E ratios, along with no reported RoE, indicates the company may still be in a growth or restructuring phase.

Additional Sources for NUTX Stock

NUTX Stock Overview

Market Cap in USD 281m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Equipment
IPO / Inception 2022-04-04

NUTX Stock Ratings

Growth 5y -35.7%
Fundamental -
Dividend 0.0%
Rel. Strength 426
Analysts 4.67/5
Fair Price Momentum 77.89 USD
Fair Price DCF -

NUTX Dividends

No Dividends Paid

NUTX Growth Ratios

Growth Correlation 3m 64.3%
Growth Correlation 12m 92.9%
Growth Correlation 5y -76.7%
CAGR 5y -19.48%
CAGR/Max DD 5y -0.19
Sharpe Ratio 12m 0.61
Alpha 458.60
Beta 2.222
Volatility 174.99%
Current Volume 175.2k
Average Volume 20d 42.2k
What is the price of NUTX stocks?
As of April 03, 2025, the stock is trading at USD 75.06 with a total of 175,178 shares traded.
Over the past week, the price has changed by +33.25%, over one month by +45.21%, over three months by +116.19% and over the past year by +434.62%.
Is Nutex Health a good stock to buy?
Probably not. Based on ValueRay Analyses, Nutex Health (NASDAQ:NUTX) is currently (April 2025) not a good stock to buy. It has a ValueRay Growth Rating of -35.69 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NUTX as of April 2025 is 77.89. This means that NUTX is currently overvalued and has a potential downside of 3.77%.
Is NUTX a buy, sell or hold?
Nutex Health has received a consensus analysts rating of 4.67. Therefor, it is recommend to buy NUTX.
  • Strong Buy: 2
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for NUTX stock price target?
According to ValueRays Forecast Model, NUTX Nutex Health will be worth about 84.1 in April 2026. The stock is currently trading at 75.06. This means that the stock has a potential upside of +12.07%.
Issuer Forecast Upside
Wallstreet Target Price 63.7 -15.2%
Analysts Target Price 55.3 -26.3%
ValueRay Target Price 84.1 12.1%